Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
414.86
-6.29 (-1.49%)
At close: Oct 9, 2025, 4:00 PM EDT
414.73
-0.13 (-0.03%)
After-hours: Oct 9, 2025, 7:35 PM EDT
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of $106.37 billion as of October 9, 2025. Its market cap has decreased by -10.41% in one year.
Market Cap
106.37B
Enterprise Value
95.86B
1-Year Change
-10.41%
Ranking
Category
Stock Price
$414.86
Market Cap Chart
Since December 1, 1998, Vertex Pharmaceuticals's market cap has increased from $611.50M to $106.37B, an increase of 17,294.31%. That is a compound annual growth rate of 21.16%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 8, 2025 | 107.98B | 4.12% |
Dec 31, 2024 | 103.71B | -1.09% |
Dec 29, 2023 | 104.85B | 41.44% |
Dec 30, 2022 | 74.13B | 32.76% |
Dec 31, 2021 | 55.83B | -9.15% |
Dec 31, 2020 | 61.46B | 9.15% |
Dec 31, 2019 | 56.30B | 32.95% |
Dec 31, 2018 | 42.35B | 11.74% |
Dec 29, 2017 | 37.90B | 107.41% |
Dec 30, 2016 | 18.27B | -40.90% |
Dec 31, 2015 | 30.92B | 8.21% |
Dec 31, 2014 | 28.57B | 64.52% |
Dec 31, 2013 | 17.37B | 91.17% |
Dec 31, 2012 | 9.09B | 31.16% |
Dec 30, 2011 | 6.93B | -2.69% |
Dec 31, 2010 | 7.12B | -8.32% |
Dec 31, 2009 | 7.76B | 69.85% |
Dec 31, 2008 | 4.57B | 48.74% |
Dec 31, 2007 | 3.07B | -34.61% |
Dec 29, 2006 | 4.70B | 71.34% |
Dec 30, 2005 | 2.74B | 223.10% |
Dec 31, 2004 | 848.90M | 5.56% |
Dec 31, 2003 | 804.20M | -33.56% |
Dec 31, 2002 | 1.21B | -34.33% |
Dec 31, 2001 | 1.84B | -56.32% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 762.99B |
Johnson & Johnson | 455.80B |
AbbVie | 409.52B |
UnitedHealth Group | 336.73B |
AstraZeneca | 266.44B |
Novo Nordisk | 261.01B |
Novartis AG | 255.35B |
Abbott Laboratories | 233.64B |